Vanguard Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $22.6M | Buy |
|
|||||
|
2022
Q3 | $12.4M | Buy |
|
|||||
|
2022
Q2 | $9.85M | Hold |
|
|||||
|
2022
Q1 | $8.39M | Buy |
|
|||||
|
2021
Q4 | $6.87M | Buy |
|
|||||
|
2021
Q3 | $9M | Buy |
|
|||||
|
2021
Q2 | $9.54M | Buy |
|
|||||
|
2021
Q1 | $10M | Buy |
|
|||||
|
2020
Q4 | $7.22M | Buy |
|
|||||
|
2020
Q3 | $6.52M | Buy |
|
|||||
|
2020
Q2 | $5.58M | Buy |
|
|||||
|
2020
Q1 | $2.37M | Buy |
|
|||||
|
2019
Q4 | $4.04M | Buy |
|
|||||
|
2019
Q3 | $5.46M | Sell |
|
|||||
|
2019
Q2 | $5.16M | Buy |
|
|||||
|
2019
Q1 | $4.97M | Buy |
|
|||||
|
2018
Q4 | $8.38M | Buy |
|
|||||
|
2018
Q3 | $16.8M | Buy |
|
|||||
|
2018
Q2 | $11.3M | Buy |
|
|||||
|
2018
Q1 | $13.1M | Buy |
|
|||||
|
2017
Q4 | $12.2M | Buy |
|
|||||
|
2017
Q3 | $15.6M | Buy |
|
|||||
|
2017
Q2 | $7.88M | Buy |
|
|||||
|
2017
Q1 | $1.41M | Sell |
|
|||||
|
2016
Q4 | $1.33M | Buy |
|
|||||
|
2016
Q3 | $2.15M | Sell |
|
|||||
|
2016
Q2 | $2.37M | Buy |
|
|||||
|
2016
Q1 | $2.25M | Buy |
|
|||||
|
2015
Q4 | $2.92M | Buy |
|
|||||
|
2015
Q3 | $2.69M | Buy |
|
|||||
|
2015
Q2 | $3.7M | Buy |
|
|||||
|
2015
Q1 | $3.03M | Buy |
|
|||||
|
2014
Q4 | $1.54M | Buy |
|
|||||
|
2014
Q3 | $1.82M | Buy |
|
|||||
|
2014
Q2 | $2.69M | Sell |
|
|||||
|
2014
Q1 | $2.29M | Buy |
|
|||||
|
2013
Q4 | $2.41M | Sell |
|
|||||
|
2013
Q3 | $3.11M | Buy |
|
|||||
|
2013
Q2 | $3.65M | Buy |
|